| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM0196-59 |
| P698 | PubMed publication ID | 8564843 |
| P50 | author | Stanley B. Prusiner | Q155380 |
| P2093 | author name string | Telling G | |
| Meiner Z | |||
| Gabizon R | |||
| Halimi M | |||
| Kahana I | |||
| P2860 | cites work | Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins | Q24564014 |
| Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation | Q33860629 | ||
| Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein | Q34294957 | ||
| Molecular biology of prion diseases | Q34534878 | ||
| Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles | Q34539307 | ||
| Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism | Q35138028 | ||
| Inherited prion diseases | Q35251034 | ||
| Separation and properties of cellular and scrapie prion proteins | Q35598678 | ||
| Proposed three-dimensional structure for the cellular prion protein | Q35618317 | ||
| Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein | Q35823555 | ||
| Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity | Q36022813 | ||
| Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils | Q36299442 | ||
| A kinetic model for amyloid formation in the prion diseases: importance of seeding | Q36385621 | ||
| Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid | Q37302673 | ||
| The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation | Q38939145 | ||
| Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease | Q39080950 | ||
| Creutzfeldt-Jakob Disease: Focus among Libyan Jews in Israel | Q39115314 | ||
| Presence of prion protein in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease | Q39241840 | ||
| Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites | Q41723952 | ||
| An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques | Q42601576 | ||
| Monitoring treatment with aminoglycoside antibiotics | Q43709580 | ||
| Prion protein peptides induce alpha-helix to beta-sheet conformational transitions | Q44458369 | ||
| Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia | Q45007616 | ||
| Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies | Q45794286 | ||
| Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. | Q45979200 | ||
| Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome | Q46931937 | ||
| Neurotoxicity of a prion protein fragment | Q48304223 | ||
| Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. | Q48420015 | ||
| Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. | Q48521519 | ||
| Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism | Q48882672 | ||
| Chemoprophylaxis of scrapie in mice | Q53030476 | ||
| Potent inhibition of scrapie-associated PrP accumulation by congo red | Q54131452 | ||
| Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin | Q59417090 | ||
| New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred | Q68292026 | ||
| A prion protein missense variant is integrated in kuru plaque cores in patients with Gerstmann‐Sträussler syndrome | Q68292323 | ||
| The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection | Q71239452 | ||
| Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate | Q72656295 | ||
| Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in Spleen | Q72739726 | ||
| Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele | Q93870994 | ||
| Counselling in general practice | Q93880164 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prion protein family | Q24724413 |
| P304 | page(s) | 59-64 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease | |
| P478 | volume | 2 |
| Q43510340 | A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. |
| Q57371794 | A C-terminal-truncated PrP Isoform Is Present in Mature Sperm |
| Q33952821 | A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases |
| Q48550880 | A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells |
| Q30734837 | Adapting protein solubility by glycosylation. N-glycosylation mutants of Coprinus cinereus peroxidase in salt and organic solutions. |
| Q59690434 | Allelic origin of the abnormal prion protein isoform in familial prion diseases |
| Q42396970 | CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE. |
| Q36136387 | Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. |
| Q35915387 | Chemical chaperones interfere with the formation of scrapie prion protein |
| Q92956802 | Detection of CWD in cervids by RT-QuIC assay of third eyelids |
| Q40136544 | Detection of chronic wasting disease prion seeding activity in deer and elk feces by real-time quaking-induced conversion |
| Q35745733 | Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain |
| Q48168745 | Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases. |
| Q39241829 | Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews |
| Q49843002 | Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein. |
| Q34305029 | Folding dynamics and energetics of recombinant prion proteins |
| Q37422460 | Genetic influence on the structural variations of the abnormal prion protein |
| Q41689443 | Genetics of prions |
| Q35122324 | Hereditary prion protein amyloidoses |
| Q46113920 | Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix |
| Q73321262 | Human TSE disease--viral or protein only? |
| Q48721370 | Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients |
| Q48963662 | Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice |
| Q33745216 | Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits |
| Q52861451 | Is there a risk of prion disease after the administration of urinary-derived gonadotrophins? |
| Q34730622 | Molecular advances in understanding inherited prion diseases |
| Q34462913 | Molecular pathology of human prion disease |
| Q48308927 | Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. |
| Q33631084 | Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP. |
| Q36012287 | PrP charge structure encodes interdomain interactions |
| Q37049002 | PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease |
| Q35798879 | Prion (PrPres) allotypes profiling: a new perspectives from mass spectrometry |
| Q21972822 | Prion Protein Biology |
| Q34304955 | Prion protein diversity and disease in the transmissible spongiform encephalopathies |
| Q36222036 | Prion protein expression in different species: analysis with a panel of new mAbs |
| Q39409269 | Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). |
| Q36774861 | Protease-sensitive prions with 144-bp insertion mutations |
| Q34989982 | Rapid antemortem detection of CWD prions in deer saliva |
| Q35903828 | Requirements for mutant and wild-type prion protein misfolding in vitro. |
| Q34474868 | Review: contribution of transgenic models to understanding human prion disease. |
| Q42670555 | Selective neuronal targeting in prion disease |
| Q33925710 | Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients |
| Q89997527 | Shedding and stability of CWD prion seeding activity in cervid feces |
| Q38507000 | The influence of PRNP polymorphisms on human prion disease susceptibility: an update. |
| Q46020428 | The prion folding problem. |
| Q33885223 | Transmissible and genetic prion diseases share a common pathway of neurodegeneration |
| Q35681248 | Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. |